Related Experiment Video
Updated: Aug 30, 2026

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats
Published on: March 8, 2019
[Pneumonectomy in disseminated fibrous-cavernous tuberculosis]
Abstract:
The paper analyzes the outcomes of pulmonectomy in 60 patients for fibrous-cavernous tuberculosis in the presence of a destructive process in the contralateral lung. It covers the clinical picture, diagnosis, and preoperative treatment policy. The destructive process in the contralateral lung was limited to 1-2 segments in the upper lobe of the lung. Pulmonectomy yielded a good clinical effect in 45 (75.0%) patients, the mortality was 6.6% (n = 4). Despite a high surgical risk, pulmonectomy in this cohort of patients was quite justifiable and a highly effective treatment.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pneumothorax-II
Clinical Manifestations:

